Skip to search formSkip to main contentSkip to account menu

PDCD1 wt Allele

Known as: PD1, Systemic Lupus Erythematosus Susceptibility 2 Gene, CD279 
Human PDCD1 wild-type allele is located in the vicinity of 2q37.3 and is approximately 9 kb in length. This allele, which encodes programmed cell… 
National Institutes of Health

Related topics

Related topics

6 relations
ApoptosisHumoral ImmunityLupus Erythematosus, SystemicSYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2 (disorder)

Broader (1)

PDCD1 gene

Narrower (1)

Programmed Cell Death Protein 1

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Abstract PD1-05: Atezolizumab in combination with trastuzumab emtansine or with trastuzumab and pertuzumab in patients with HER2-positive breast cancer and atezolizumab with doxorubicin and…
Background: Chemotherapy and HER2-targeted antibodies are standard-of-care (SOC) treatments (tx) for HER2+ breast cancer (BC) in… 
2019
2019
Different Triple-Negative Breast Cancer Tumor Cell Lysates (TCLs) Induce Discrepant Anti-Tumor Immunity by PD1/PDL-1 Interaction
Background TCL-based immunotherapy has been applied in the field cancer therapy. However, it is un clear whether this therapy can… 
2018
2018
Abstract 4547: Characterization of the LAG-3 targeting antibody BI 754111 in monotherapy and in combination with the anti-PD-1 antibody BI 754091
Lymphocyte activation gene-3 (LAG-3) is an inhibitory receptor involved in maintaining immunological tolerance via regulation of… 
2018
2018
Anti‐PD1 in Merkel cell carcinoma and cutaneous squamous cell carcinoma, description of five cases and recent data from the literature
Merkel cell carcinoma (MCC) and cutaneous squamous cell carcinoma (CSCC) are tumors of the elderly due to UV exposure with… 
2018
2018
Cellular Pharmacology of Palladinum(III) Hematoporphyrin IX Complexes: Solution Stability, Antineoplastic and Apoptogenic Activity, DNA Binding, and Processing of DNA-Adducts
Two paramagnetic PdIII complexes of hematoporphyrin IX ((7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-21H-23H-porphyn-2,18… 
2018
2018
Abstract 2724: YIV906 (PHY906) enhanced the antitumor activity of immune checkpoint blockade therapy: Anti-PD1 against liver cancer
Immune checkpoint blockade therapy has recently been recognized as a breakthrough in cancer treatment. Recently, FDA has approved… 
2018
2018
Lichen plan chez des patients traités par anti-PD1 : 6 cas
2016
2016
Sclérodermie linéaire survenue au cours d’un traitement par nivolumab : premier cas décrit☆
2011
2011
Altered TNF-α and IFN-γ levels associated with PD1 but not TNFA polymorphisms in patients with chronic HBV infection.
1993
1993
Laser, gamma irradiation, and chemotherapy in treatment of experimental tumors sensitized by porphyrins
The new hematoporphyrin derivatives--HpD-1 and dimethoxyhematoporphyrin--DMHp were studied. Their physico-chemical properties… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)